| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.69M | - | |
| VP | 141.5K | $11.21M | - | |
| Other | 87.3K | $6.91M | - | |
| VP | 73.6K | $5.82M | -15,000 | |
| CFO | 70.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Blum Robert I51 | President &CEO | Sell | 8,743 | $42.88 | $374,899.84 | -2.1% | -27.2% | +41.5% | |
| Feb 18, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $45.98 | $91,960.00 | -1.7% | -32.3% | +47.6% | |
| Feb 4, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $48.06 | $96,120.00 | -1.7% | -25.5% | +29.1% | |
| Jan 21, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $45.92 | $91,840.00 | -1.7% | -17.2% | +37.6% | |
| Jan 7, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $49.32 | $98,640.00 | -1.7% | -25.8% | +34.9% | |
| Dec 16, 2024 | Wierenga Wendall59 | Director | Sale+OE | 742 | $48.61 | $36,068.62 | -2.9% | -8.4% | +26.5% | |
| Dec 11, 2024 | Henderson John T65 | Director | Sale+OE | 1,780 | $50.42 | $89,747.60 | -4.4% | -12.4% | +19.9% | |
| Dec 10, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $50.64 | $369,639.00 | -3.0% | -14.3% | +19.3% | |
| Dec 2, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $50.76 | $253,800.00 | -1.2% | -15.3% | +25.4% | |
| Nov 26, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $50.16 | $366,181.00 | -3.1% | -7.5% | +31.0% |